Tilray | TRLY - Capital Ordinário

Preço das Ações
7.28
Mudança Diária
-0.26 -3.45%
Mensal
-22.22%
Anual
970.59%
Q2 Previsão
7.13




Capital Ordinário Alterar Data
Acasti Pharma USD 1000 261.04M 2024-12
Akebia Therapeutics USD 265.42M 199K 2025-12
Alaunos Therapeutics USD 2.21M 131K 2025-09
Aurora Cannabis CAD 56.71M 134.13K 2025-12
Canopy Growth CAD 368.28M 35.9M 2025-12
Cronos Group USD 376.26M 5.33M 2026-03
Dianthus Therapeutics USD 43.22M 368.53K 2025-12
Divis Laboratories Ltd INR 265.47M 264.53M 2025-09
Ionis Pharmaceuticals USD 165.9M 3.93M 2026-03
IQVIA Holdings USD 166.9M 2.7M 2026-03
Knight Therapeutics CAD 99.68M 24.66K 2025-09
Moderna USD 391M 2M 2025-09
Organigram Holdings CAD 135.13M 671.75K 2025-12
Organon & Co USD 260.32M 333K 2025-12
Revvity USD 111.8M 1.57M 2026-03
Tectonic Therapeutic USD 18.74M 25.03K 2025-12
Tilray USD 116.52M 5.01M 2025-09
Viatris USD 1.16B 5.27M 2026-03
Xeris Pharmaceuticals USD 166.22M 687.16K 2025-12
Zealand Pharma A/S 70.61M 319.68K 2025-12